Inflammation in deep vein thrombosis and the development of post-thrombotic syndrome: A prospective study

Journal of Thrombosis and Haemostasis

Volumn 7, Issue 4, 2009, Pages 582-587

  Roumen Klappe, Edith M ^a   Janssen, M C H ^a   Van Rossum, J ^a   Holewijn, S ^a   Van Bokhoven, M M J A ^b   Kaasjager, K ^c   Wollersheim, H ^a   Den Heijer, M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^c RIJNSTATE HOSPITAL   (Netherlands)

Author keywords

C reactive protein; Deep vein thrombosis; Interleukin 6; Post thrombotic syndrome; Venous outflow resistance

Indexed keywords

ANTIVITAMIN K; C REACTIVE PROTEIN; INTERLEUKIN 6; LOW MOLECULAR WEIGHT HEPARIN;

ACUTE DISEASE; ADULT; AGED; ARTICLE; DEEP VEIN THROMBOSIS; DISEASE CLASSIFICATION; FEMALE; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POSTTHROMBOSIS SYNDROME; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SCORING SYSTEM; VASCULAR RESISTANCE; VEIN BLOOD FLOW;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; POSTTHROMBOTIC SYNDROME; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; VENOUS INSUFFICIENCY; VENOUS THROMBOSIS;

EID: 63049093422     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2009.03286.x     Document Type: Article

References (27)

1. Kahn SR. Frequency and determinants of the postthrombotic syndrome after venous thromboembolism. Curr Opin Pulm Med 2006; 12: 299-303.
2. Kahn SR, Shbaklo H, Lamping DL, Holcroft CA, Shrier I, Miron MJ, Roussin A, Desmarais S, Joyal F, Kassis J, Solymoss S, Desjardins L, Johri M, Ginsberg JS. Determinants of health-related quality of life during the two years following deep venous thrombosis. J Thromb Haemost 2008; 6: 1105-12.
3. Bergqvist D, Jendteg S, Johansen L, Persson U, Odegaard K. Cost of long-term complications of deep venous thrombosis of the lower extremities: An analysis of a defined patient population in Sweden. Ann Intern Med 1997; 126: 454-7.
4. Kolbach DN, Sandbrink MW, Hamulyak K, Neumann HA, Prins MH. Non-pharmaceutical measures for prevention of post-thrombotic syndrome. Cochrane Database Syst Rev 2003; 3: CD004174.
5. Roumen-Klappe EM, den Heijer M, Janssen MC, van der Vleuten C, Thien T, Wollersheim H. The post-thrombotic syndrome: Incidence and prognostic value of non-invasive venous examinations in a six-year follow-up study. Thromb Haemost 2005; 94: 825-30.
6. Froehlich JB, Prince MR, Greenfield LJ, Downing LJ, Shah NL, Wakefield TW. "Bull's-eye"sign on gadolinium-enhanced magnetic resonance venography determines thrombus presence and age: A preliminary study. J Vasc Surg 1997; 26: 809-16.
7. Meissner MH, Wakefield TW, Ascher E, Caprini JA, Comerota AJ, Eklof B, Gillespie DL, Greenfield LJ, He AR, Henke PK, Hingorani A, Hull RD, Kessler CM, McBane RD, McLafferty R. Acute venous disease: Venous thrombosis and venous trauma. J Vasc Surg 2007; 46 (Suppl S): 25S-53S.
8. Roumen-Klappe EM, den Heijer M, van Uum SH, van der Vleuten C, van der Graaf F, Wollersheim H. Inflammatory response in the acute phase of deep vein thrombosis. J Vasc Surg 2002; 35: 701-6.
9. Haenen JH, Janssen MC, van Langen H, van Asten WN, Wollersheim H, van't Hof MA, Skotnicki SH, Thien T. The postthrombotic syndrome in relation to venous hemodynamics, as measured by means of duplex scanning and strain-gauge plethysmography. J Vasc Surg 1999; 29: 1071-6.
10. Klein Rouweler BJF, Brakkee AJM, Kuiper JP. Plethysmographic measurement of venous flow resistance and venous capacity in the human leg. Part One: Method. Phlebology 1989; 4: 241-50.
11. Porter JM, Moneta GL. Reporting standards in venous disease: An update. International Consensus Committee on Chronic Venous Disease. J Vasc Surg 1995; 21: 635-45.
12. Haenen JH, Janssen MC, van Langen H, van Asten WN, Wollersheim H, Heystraten FM, Skotnicki SH, Thien T. Duplex ultrasound in the hemodynamic evaluation of the late sequelae of deep venous thrombosis. J Vasc Surg 1998; 27: 472-8.
13. Haenen JH, van Langen H, Janssen MC, Wollersheim H, van't hof MA, van Asten WN, Skotnicki SH, Thien T. Venous duplex scanning of the leg: range, variability and reproducibility. Clin Sci (Lond) 1999; 96: 271-7.
14. Haenen JH, Janssen MC, Wollersheim H, van't Hof MA, de Rooij MJ, van Langen H, Skotnicki SH, Thien T. The development of postthrombotic syndrome in relationship to venous reflux and calf muscle pump dysfunction at 2years after the onset of deep venous thrombosis. J Vasc Surg 2002; 35: 1184-9.
15. Eklof B, Rutherford RB, Bergan JJ, Carpentier PH, Gloviczki P, Kistner RL, Meissner MH, Moneta GL, Myers K, Padberg FT, Perrin M, Ruckley CV, Smith PC, Wakefield TW, American Venous Forum International Ad Hoc Committee for Revision of the CEAP Classification. Revision of the CEAP classification for chronic venous disorders: Consensus statement. J Vasc Surg 2004; 40: 1248-52.
16. Prandoni P, Villalta S, Bagatella P, Rossi L, Marchiori A, Piccioli A, Bernardi E, Girolami B, Simioni P, Girolami A. The clinical course of deep-vein thrombosis. Prospective long- term follow-up of 528 symptomatic patients. Haematologica 1997; 82: 423-8.
17. Callas PW, Pastides H, Hosmer DW. Empirical comparisons of proportional hazards, poisson, and logistic regression modeling of occupational cohort data. Am J Ind Med 1998; 33: 33-47.
18. Mittlbock M, Heinzl H. A note on R2 measures for Poisson and logistic regression models when both models are applicable. J Clin Epidemiol 2001; 54: 99-103.
19. Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004; 159: 702-6.
20. Kahn SR. The post-thrombotic syndrome: Progress and pitfalls. Br J Haematol 2006; 134: 357-65.
21. Kolbach DN, Neumann HA, Prins MH. Definition of the post-thrombotic syndrome, differences between existing classifications. Eur J Vasc Endovasc Surg 2005; 30: 404-14.
22. van Dongen CJ, Prandoni P, Frulla M, Marchiori A, Prins MH, Hutten BA. Relation between quality of anticoagulant treatment and the development of the postthrombotic syndrome. J Thromb Haemost 2005; 3: 939-42.
23. Wakefield TW, Henke PK. The role of inflammation in early and late venous thrombosis: Are there clinical implications? Semin Vasc Surg 2005; 18: 118-29.
24. Deatrick KB, Eliason JL, Lynch EM, Moore AJ, Dewyer NA, Varma MR, Pearce CG, Upchurch GR, Wakefield TW, Henke PK. Vein wall remodeling after deep vein thrombosis involves matrix metalloproteinases and late fibrosis in a mouse model. J Vasc Surg 2005; 42: 140-8.
25. Myers DD Jr, Henke PK, Bedard PW, Wrobleski SK, Kaila N, Shaw G, Meier TR, Hawley AE, Schaub RG, Wakefield TW. Treatment with an oral small molecule inhibitor of P selectin (PSI-697) decreases vein wall injury in a rat stenosis model of venous thrombosis. J Vasc Surg 2006; 44: 625-32.
26. Downing LJ, Strieter RM, Kadell AM, Wilke CA, Greenfield LJ, Wakefield TW. Low-dose low-molecular-weight heparin is anti-inflammatory during venous thrombosis. J Vasc Surg 1998; 28: 848-54.
27. Moaveni DK, Lynch EM, Luke C, Sood V, Upchurch GR, Wakefield TW, Henke PK. Vein wall re-endothelialization after deep vein thrombosis is improved with low-molecular-weight heparin. J Vasc Surg 2008; 47: 616-24.